KM
LLY icon

Kalos Management’s Eli Lilly LLY Stock Holding History

Kalos Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-862
Closed -$279K – 76
2022
Q2 		$279K Buy
+862
New +$259K 0.37% 82
2019
Q4 		– Sell
-25,092
Closed -$2.8M – 212
2019
Q3 		$2.8M Sell
25,092
-10,364
-29% -$1.15M 1.12% 24
2019
Q2 		$4.09M Buy
35,456
+7,418
+26% +$874K 1.86% 12
2019
Q1 		$3.64M Sell
28,038
-7,277
-21% -$885K 2.35% 10
2018
Q4 		$4.09M Sell
35,315
-2,295
-6% -$256K 1.99% 11
2018
Q3 		$4.04M Sell
37,610
-304
-0.8% -$30.4K 2.17% 8
2018
Q2 		$3.23M Buy
+37,914
New +$3.11M 1.47% 18
2015
Q4 		– Hold
0
– – – 416

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Kalos Management's LLY Position: Q3 2022 in Review

Kalos Management sold out of Eli Lilly (LLY) in Q3 2022, closing a stake of 862 shares — an estimated $279K sold.

Kalos Management first reported a position in LLY in Q2 2018 and held it in 7 quarters. The position peaked at $4.09M in Q2 2019. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Kalos Management reported no remaining Eli Lilly position as of Q3 2022 after selling out during the quarter.
  • Kalos Management sold 862 Eli Lilly shares in Q3 2022, an estimated $279K.
  • Kalos Management first reported a position in Eli Lilly in Q2 2018 and held it in 7 quarters.
  • Kalos Management's Eli Lilly position peaked at $4.09M in Q2 2019.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Kalos Management's 13F filing for Q3 2022, filed 21 Nov 2022.